Literature DB >> 8933859

Surfactant treatment in experimental Escherichia coli pneumonia.

G W Song1, B Robertson, T Curstedt, X Z Gan, W X Huang.   

Abstract

BACKGROUND: Deterioration of lung function in bacterial pneumonia may in part be due to inactivation of endogenous surfactant. We investigated the effects of surfactant treatment on gas exchange and lung morphology in an experimental model of pneumonia caused by Escherichia coli.
METHODS: A total of 117 adult rats received via the trachea 2 ml/kg body weight of a standard suspension of Escherichia coli (4 x 10(9) bacteria/ml). After 2-3 days, 31 of the infected animals showed symptoms of respiratory failure with PaO2 < 27 kPa during ventilation with 100% O2. All these animals were kept in a multi-plethysmograph system and ventilated for 45 min with a tidal volume of 6 ml/kg, a frequency of 30/min, an inspiration/expiration ratio of 1:1, and a positive end-expiratory pressure of 0.2 kPa. After 15 min of mechanical ventilation, animals were divided in three treatment groups, receiving via the airways (1) no material, (2) normal saline (2 ml/kg), or (3) Curosurf, 80 mg/ml (2 ml/kg). Ten healthy animals served as controls. Lung-thorax compliance and blood gases were measured 15 and 30 min after surfactant treatment. After the period of ventilation, animals were killed, and the left lung was weighed and fixed in formalin for histological examination. The right lung was washed in situ with normal saline via the tracheal tube. Total phospholipids, and levels of phosphatidylcholine (PC) and protein in lavage fluid were determined.
RESULTS: In comparison with pre-treatment values, average PaO2 at 30 min was increased by 76% in animals receiving Curosurf (P < 0.01), but did not improve in the other groups. The left lung weight/body weight ratio showed a nearly 3-fold increase in infected animals in comparison with normal controls. There was also a 3-fold increase in the protein content of lung lavage fluid from infected rats, but values for total phospholipids and PC content were unchanged in animals not receiving surfactant. Histological examination of the lungs showed wide-spread non-specific pneumonia in infected animals, but no difference in alveolar air expansion between surfactant-treated and non-treated ones.
CONCLUSION: Surfactant replacement significantly improves oxygenation in rats with E. coli pneumonia, without affecting lung-thorax compliance during mechanical ventilation or alveolar expansion pattern in lungs fixed by conventional methods.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8933859     DOI: 10.1111/j.1399-6576.1996.tb05580.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  6 in total

1.  Influence of modified natural or synthetic surfactant preparations on growth of bacteria causing infections in the neonatal period.

Authors:  P Rauprich; O Möller; G Walter; E Herting; B Robertson
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

2.  An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals.

Authors:  Gustavo Matute-Bello; Gregory Downey; Bethany B Moore; Steve D Groshong; Michael A Matthay; Arthur S Slutsky; Wolfgang M Kuebler
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05       Impact factor: 6.914

3.  The protective effects of Ambroxol in Pseudomonas aeruginosa-induced pneumonia in rats.

Authors:  Xiwen Gao; Yi Huang; Yipin Han; Chun-Xue Bai; Guifang Wang
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

Review 4.  Surfactant alteration and replacement in acute respiratory distress syndrome.

Authors:  A Günther; C Ruppert; R Schmidt; P Markart; F Grimminger; D Walmrath; W Seeger
Journal:  Respir Res       Date:  2001-10-12

5.  Inhibition of pulmonary nuclear factor kappa-B decreases the severity of acute Escherichia coli pneumonia but worsens prolonged pneumonia.

Authors:  James Devaney; Gerard F Curley; Mairead Hayes; Claire Masterson; Bilal Ansari; Timothy O'Brien; Daniel O'Toole; John G Laffey
Journal:  Crit Care       Date:  2013-04-27       Impact factor: 9.097

6.  In vivo effect of pneumonia on surfactant disaturated-phosphatidylcholine kinetics in newborn infants.

Authors:  Maddalena Facco; Matteo Nespeca; Manuela Simonato; Ilena Isak; Giovanna Verlato; Gianluca Ciambra; Chiara Giorgetti; Virgilio P Carnielli; Paola E Cogo
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.